Elamipretide Improves Mitochondrial Function in Mitochondrial Trifunctional Protein‐Deficient Mice and Human Fibroblasts
Journal of Inherited Metabolic Disease · 2026
DOI: 10.1002/jimd.70132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2026. Verfasst von Eduardo Vieira Neto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Genetic and Genomic Medicine Division, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsy…. Hauptthemen laut MEDLINE: Fibroblasts, Mitochondrial Trifunctional Protein, Mitochondria, Oligopeptides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Children's Neuroscience Institute Interdisciplinary Neuroscience Award, UPMC Children's Hospital of Pittsburgh Foundation.
Abstract (Originalsprache)
Mitochondrial trifunctional protein (TFP) deficiency is an inherited disorder of long‐chain fatty acid β‐oxidation (FAO). TFP is a heteromeric enzyme composed of two α and two β‐subunits. Despite early detection and dietary treatment, TFP deficiency patients often develop hypoglycemia, rhabdomyolysis, cardiomyopathy, and peripheral neuropathy. Degenerative retinopathy and milder peripheral neuropathy occur in patients with an isolated deficiency of the αTFP subunit of long‐chain 3‐hydroxyacyl‐CoA dehydrogenase (LCHAD) activity. Triheptanoin treatment improves most complications, but not peripheral neuropathy and retinopathy. Notably, TFP also carries a fourth enzymatic function involved in cardiolipin remodeling, which we previously found to be impaired in TFP/LCHAD deficiency. We therefore tested whether elamipretide, a synthetic cardiolipin‐binding peptide, could improve mitochondrial function and cardiolipin levels in βTFP‐deficient mice and patient‐derived fibroblasts. Mice were treated with elamipretide delivered by osmotic minipump and challenged with treadmill exercise or cold stress after fasting. βTFP‐deficient mice treated with elamipretide showed improved exercise endurance, but cold tolerance was not altered. Liver mitochondria from male βTFP‐deficient mice demonstrated improved FAO‐ETC enzyme activities. However, cardiolipin content and composition were unchanged. In patient fibroblasts, elamipretide produced a possible genotype‐dependent increase in mitochondrial bioenergetics and a reduction in ROS. These results support a mechanism in which elamipretide stabilizes between FAO enzymes and ETC complexes, thereby improving mitochondrial function independently of changes in cardiolipin levels. Elamipretide thus emerges as a potential therapeutic agent for TFP/LCHAD deficiency, warranting further preclinical studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genetic and Genomic Medicine Division, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Pediatrics, Children's Neuroscience Institute, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Biological Sciences, Kenneth P. Dietrich School of Arts and Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- School of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
- Department of Human Genetics, School of Public Health, Center for Rare Disease Therapy, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Eduardo Vieira Neto
Förderung
- Children's Neuroscience Institute Interdisciplinary Neuroscience Award
- UPMC Children's Hospital of Pittsburgh Foundation
Zitieren
APA
Vieira Neto, E., Wang, M., Szuminsky, A. J., Ferraro, L., Basu, S., Zhao, X., Karunanidhi, A., Wang, Y., & Vockley, J. (2026). Elamipretide Improves Mitochondrial Function in Mitochondrial Trifunctional Protein‐Deficient Mice and Human Fibroblasts. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70132
Vancouver
Vieira Neto E, Wang M, Szuminsky AJ, Ferraro L, Basu S, Zhao X, et al. Elamipretide Improves Mitochondrial Function in Mitochondrial Trifunctional Protein‐Deficient Mice and Human Fibroblasts. Journal of Inherited Metabolic Disease. 2026. doi:10.1002/jimd.70132
BibTeX
@article{VieiraNeto2026,
author = {Vieira Neto, Eduardo and Wang, Meicheng and Szuminsky, Austin J and Ferraro, Lethicia and Basu, Shakuntala and Zhao, Xuejun and Karunanidhi, Anuradha and Wang, Yudong and Vockley, Jerry},
title = {Elamipretide Improves Mitochondrial Function in Mitochondrial Trifunctional Protein‐Deficient Mice and Human Fibroblasts},
journal = {Journal of Inherited Metabolic Disease},
year = {2026},
doi = {10.1002/jimd.70132}
}
EUVIMED